NGS Sample Preparation Market Introduction:

Next Generation Sequencing (NGS) is a genome analysis platform which is more affordable, rapid and accurate. NGS is built upon first generation sequencing technologies to generate accurate and cost-effective results of sequencing. Next generation sequencing is a powerful platform which has made it possible to simultaneously sequence thousands to millions of DNA molecules. This powerful tool is revolutionizing areas such as genetic diseases, personalized medicine, and clinical diagnostics by providing a high throughput option with the capability for sequencing multiple individuals at the same time.

All NSG platforms need a library which can be prepared by generating a collection of DNA fragments for the sequencing. NGS libraries are generally prepared by fragmenting a sample of genomic DNA and ligating both fragment ends with specialized adapters. These adapter sequences provide a universal priming site to sequence primers by allowing for library hybridization to the sequencing chips. An alternative process called tagmentation constitutes a combination of fragmentation and ligation reactions into a single step. These adapter-ligated fragments are later PCR amplified and gel purified. 

NGS Sample Preparation Market – Competition Landscape

Rise in adoption of genomics for developing innovative diagnostic tools and tests and development of precision & personalized medicines has led to surge in collaboration among NGS tools & service providers and diagnostic & pharmaceutical companies. For an instance, in June 2017, Bristol-Myers Squibb Company and QIAGEN entered into an agreement for development gene expression profiles (GEPs) using NGS technology for former’s immuno-oncology (I-O) therapies in cancer treatment. In 2017, Illumina partnered with China’s KingMed Diagnostics to use its NGS technology for oncology and genetic disease testing. 

Identify the key factors that will drive your company’s growth, Request a brochure of this report here 

Illumina, Inc.:

The US based, Illumina, Inc. is a manufacturer and provider of life science solutions with focus on gene sequencing and analysis. It is one of the leading supplier for NGS sample preparation tools. Illumina, Inc. is pioneer in providing affordable NGS platforms for researchers.

Agilent Technologies, Inc.:

Company offers its NGS sample preparation solutions under its Diagnostics and Genomics Group. Agilent has adopted inorgcanic growth strategies to expand its NGS solutions portfolio, for an instance company has acquired Lasergen which was engaged in development of DNA sequencing technologies, in 2017, Agilent acquired molecular and sample barcoding patents from Population Genetics Technologies. In February 2019, Agilent Technologies launched its NGS library preparation systems designed specifically to run complex DNA sequencing assays. 

Other key players operating in the in the global NGS sample preparation market include Thermo Fisher Scientific, QIAGEN, BD, Pacific Biosciences of California, Inc., 10x Genomics, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, and Eurofins Scientific. These players have adopted strategies such as agreements, partnerships, new product development, and collaborations to gain competitive advantage in the global NGS sample preparation market. 

NGS Sample Preparation Market Dynamics

Increase in application of NGS in genomics and diagnostic research -

NGS tools manufacturers and service providing companies are collaborating on development of innovative and more precise diagnostic tools. Genetic testing is advancing its application in pre-diagnosis of various chronic and genetic diseases such as cancer, diabetes, certain neural disorders and others. As the demand for quality healthcare and preventive diagnostics is likely to surge it is anticipated to augment the use of NGS technique, thereby propelling the NGS sample preparation market. 

Expanding operations in future? To get the perfect launch ask for a custom report here 

Accurate, Rapid and Affordable Platforms for Gene Sequencing & Analysis -

NGS offers accurate and rapid gene sequencing and analysis for researchers. As the adoption for genetics in healthcare and other life sciences related industries is growing, more and more players are introducing their products and services for NGS sample preparation. With the surge in number of suppliers, the cost for NGS sample preparation is likely to decline. Further key players are striving to introduce more affordable and accurate NGS solutions. For an instance, in 2014 Agilent Technologies, Inc. launched its HiSeq X10 NGS platform which made NGS affordable to many researchers across the globe, its recent introduction of NovaSeq NGS platform is likely to revolutionize the NGS processes by further reducing the procedure costs.

Limited Availability in Emerging Markets & Lack of skilled operators hinders the market growth

Although costs related to NGS have reduced to an extent; however, it is not adopted across developing markets. Further lack of skilled workforce to operate and use advanced NGS tools and post sequencing analysis are likely to hamper the growth of the NGS sample preparation market in emerging markets such as Latin America, Asia Pacific and Middle East & Africa. 

NGS Sample Preparation Market Segmentation

Based on the product type, the NGS sample preparation market can be segmented into

  • Sequencer Systems
  • Consumables & Reagents

Based on the workflow, the NGS sample preparation market can be segmented into

  • Target Enrichment
  • Library preparation
  • Quality control

Based on the technology, the NGS sample preparation market can be segmented into

  • Ion semiconductor sequencing
  • Sequencing by synthesis (SBS)
  • Nanopore sequencing
  • Single-molecule real-time sequencing (SMRT)
  • Others

Based on the application, the NGS sample preparation market can be segmented into

  • Diagnostics
  • Drug discovery
  • Agricultural & animal research
  • Others

Based on the end-use industry, the NGS sample preparation market can be segmented into

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes & Research Centers
  • Others 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis. 

.